SNO Bio is an early-stage biopharmaceutical company developing novel therapeutics targeting enzymes associated with S-nitrosylation, a post-translational protein modification operating as a fundamental biological mechanism controlling cell signaling.

Industry Sector
Biomedical & Health Tech

Founded
2020

JumpStart Investment
Evergreen Fund